Article
Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.
Thrombosis research - 1 Feb 2022
Wang Xinrui, Tang Borui, Zhou Meng, Liu Lihong, Feng Xin, Wang Xin, Qiu Kui
Abstract excerpt
OBJECTIVE: To evaluate the efficacy and safety of genotype-guided dosing (GD) strategies compared to non-genotype-guided dosing (non-GD) strategies for warfarin. METHODS: Databases were searched up to July 2021. Meta-analysis was conducted with the Review Manager software (version 5.4) and R (version 4.0.5). Risk ratio (RR), mean difference (MD), and 95% confidence intervals (CIs) were used. Subgroup analyses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.